Medlicott, Natalie J
University of Otago
4 papers on CoChatORCID 0000-0001-9778-1947
Most cited papers
- Verified
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders
Glue, P., Medlicott, N. J., Harland, S., Neehoff, S., Anderson-Fahey, B., Le Nedelec, M., Gray, A., & McNaughton, N. (2017) · Journal of Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 144
- Verified
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
Glue, P., Neehoff, S. M., Medlicott, N. J., Gray, A., Kibby, G., & McNaughton, N. (2018) · Journal of Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 100
- Verified
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
Glue, P., Medlicott, N. J., Neehoff, S., Surman, P., Lam, F., Hung, N., & Hung, C.-T. (2020) · Therapeutic Advances in Psychopharmacology
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 42
- Verified
Population pharmacokinetic–pharmacodynamic modelling to describe the effects of paracetamol and N‐acetylcysteine on the international normalized ratio
Owens, K. H., Medlicott, N. J., Zacharias, M., Whyte, I. M., Buckley, N. A., & Reith, D. M. (2015) · Clinical and Experimental Pharmacology and Physiology
Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free